Related references
Note: Only part of the references are listed.Targeting Abnormal Hematopoietic Stem Cells in Chronic Myeloid Leukemia and Philadelphia Chromosome-Negative Classical Myeloproliferative Neoplasms
Yammy Yung et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Intracerebroventricular Treatment with 2-Hydroxypropyl-β-Cyclodextrin Decreased Cerebellar and Hepatic Glycoprotein Nonmetastatic Melanoma Protein B (GPNMB) Expression in Niemann-Pick Disease Type C Model Mice
Madoka Fukaura et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Chronic Myeloid Leukemia: A Model Disease of the Past, Present and Future
Valentina R. Minciacchi et al.
CELLS (2021)
Differential mode of cholesterol inclusion with 2-hydroxypropyl-cyclodextrins increases safety margin in treatment of Niemann-Pick disease type C
Yusei Yamada et al.
BRITISH JOURNAL OF PHARMACOLOGY (2021)
Naked antisense double-stranded DNA oligonucleotide efficiently suppresses BCR-ABL positive leukemic cells
Toshimi Hoshiko et al.
INVESTIGATIONAL NEW DRUGS (2020)
The leukaemia stem cell: similarities, differences and clinical prospects in CML and AML
David Vetrie et al.
NATURE REVIEWS CANCER (2020)
Autophagy and mitochondrial metabolism: insights into their role and therapeutic potential in chronic myeloid leukaemia
Pablo Baquero et al.
FEBS JOURNAL (2019)
Targeting quiescent leukemic stem cells using second generation autophagy inhibitors
Pablo Baquero et al.
LEUKEMIA (2019)
The Roles of Autophagy in Cancer
Chul Won Yun et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Induction of mitophagy-mediated antitumor activity with folate-appended methyl-β-cyclodextrin
Kazuhisa Kameyama et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2017)
The novel BMI-1 inhibitor PTC596 downregulates MCL-1 and induces p53-independent mitochondrial apoptosis in acute myeloid leukemia progenitor cells
Y. Nishida et al.
BLOOD CANCER JOURNAL (2017)
Diagnosis and Management of Leukemic and Lymphomatous Meningitis
Hemant Murthy et al.
CANCER CONTROL (2017)
ATG7 regulates energy metabolism, differentiation and survival of Philadelphia-chromosome-positive cells
Maria Karvela et al.
AUTOPHAGY (2016)
Comparative Study of the Anti-leukemic Effects of Imatinib Mesylate, Glivec™ Tablet and Its Generic Formulation, OHK9511
Masako Yokoo et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2015)
Reactive oxygen species and mitochondria: A nexus of cellular homeostasis
Joe Dan Dunn et al.
REDOX BIOLOGY (2015)
2-Hydroxypropyl-β-Cyclodextrin Acts as a Novel Anticancer Agent
Masako Yokoo et al.
PLOS ONE (2015)
The core autophagy protein ATG4B is a potential biomarker and therapeutic target in CML stem/progenitor cells
Katharina Rothe et al.
BLOOD (2014)
The folate receptor as a rational therapeutic target for personalized cancer treatment
Yehuda G. Assaraf et al.
DRUG RESISTANCE UPDATES (2014)
Ever-advancing chronic myeloid leukemia treatment
Shinya Kimura et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2014)
Inhibition of mTOR-Dependent Autophagy Sensitizes Leukemic Cells to Cytarabine-Induced Apoptotic Death
Mihajlo Bosnjak et al.
PLOS ONE (2014)
Involvement of Autophagy in Antitumor Activity of Folate-appended Methyl-β-cyclodextrin
Risako Onodera et al.
SCIENTIFIC REPORTS (2014)
Effects of intracerebroventricular administration of 2-hydroxypropyl-beta-cyclodextrin in a patient with Niemann-Pick Type C disease
Muneaki Matsuo et al.
MOLECULAR GENETICS AND METABOLISM REPORTS (2014)
Effects of cyclodextrin in two patients with Niemann-Pick Type C disease
Muneaki Matsuo et al.
MOLECULAR GENETICS AND METABOLISM (2013)
Potential use of Folate-appended Methyl-β-Cyclodextrin as an Anticancer Agent
Risako Onodera et al.
SCIENTIFIC REPORTS (2013)
Methyl-β-cyclodextrin induces programmed cell death in chronic myeloid leukemia cells and, combined with imatinib, produces a synergistic downregulation of ERK/SPK1 signaling
Jun Yan et al.
ANTI-CANCER DRUGS (2012)
Autophagic degradation of the BCR-ABL oncoprotein and generation of antileukemic responses by arsenic trioxide
Dennis J. Goussetis et al.
BLOOD (2012)
Design and evaluation of folate-appended methyl-β-cyclodextrin as a new antitumor agent
Risako Onodera et al.
JOURNAL OF INCLUSION PHENOMENA AND MACROCYCLIC CHEMISTRY (2011)
Autophagy is essential to suppress cell stress and to allow BCR-Abl-mediated leukemogenesis
B. J. Altman et al.
ONCOGENE (2011)
Autophagy Inhibition Enhances Daunorubicin-Induced Apoptosis in K562 Cells
Weidong Han et al.
PLOS ONE (2011)
Autophagy contributes to therapy-induced degradation of the PML/RARA oncoprotein
Pauline Isakson et al.
BLOOD (2010)
Regulation of Autophagy by Reactive Oxygen Species (ROS): Implications for Cancer Progression and Treatment
Meghan B. Azad et al.
ANTIOXIDANTS & REDOX SIGNALING (2009)
Targeting autophagy potentiates tyrosine kinase inhibitor-induced cell death in Philadelphia chromosome-positive cells, including primary CML stem cells
Cristian Bellodi et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Targeting autophagy augments the anticancer activity of the histone deacetylase inhibitor SAHA to overcome Bcr-Abl-mediated drug resistance
Jennifer S. Carew et al.
BLOOD (2007)
Establishment and characterization of a novel imatinib-sensitive chronic myeloid leukemia cell line MYL, and an imatinib-resistant subline MYL-R showing overexpression of Lyn
Takuo Ito et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2007)
NS-187, a potent and selective dual Bcr-Abl/Lyn tyrosine kinase inhibitor, is a novel agent for imatinib-resistant leukemia
S Kimura et al.
BLOOD (2005)
Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay
N Parker et al.
ANALYTICAL BIOCHEMISTRY (2005)
Cyclodextrin-based pharmaceutics: Past, present and future
ME Davis et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia
SG O'Brien et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Share Paper
